Delivery Order SPE2DB22D2007-SPE2DB25FJ4YW
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,748.14 on November 4, 2025, for the supply of INGREZZA 40 MG capsules (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) with a ceiling value of $8,055.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp for the supply of INGREZZA 60 mg capsules (30-count units) on December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is December 31, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on October 15, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, competitively awarded contract (without set-aside designation) represents a purchase of pharmaceutical inventory to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of INGREZZA 60 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of June 17, 2025, and identifies AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of INGREZZA 60 mg capsules in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,267.66 under a firm fixed-price delivery order structure, with performance to be completed by December 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. The delivery...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG Capsule in a 30-count quantity under a firm fixed-price contract with a ceiling value of $3,676.12. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- On July 29, 2025, the Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4YWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of INGREZZA 40 mg capsules (30-count packages) with a ceiling value of $7,352.24. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 6, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive medical supply chain capabilities. The company's extensive portfolio with the Defense Logistics Agency demonstrates its ability to fulfill a wide range of pharmaceutical procurement requirements, from specialty medications to brand-name and generic drugs. INGREZZA, an atypical antipsychotic medication, represents one of the neurological treatments within the company's federal contract deliveries. As a prime vendor under the DLA's pharmaceutical support framework, AmerisourceBergen continues to provide essential medical commodities to support military healthcare programs domestically and globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/15/25 |